ABT(Abbott Laboratories) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $43.08B | $43.65B | $40.11B | $41.95B | $44.33B |
| 毛利润 | $24.54B | $24.51B | $22.13B | $23.24B | $25.01B |
| 营业利润 | $8.43B | $8.36B | $6.48B | $6.83B | $8.05B |
| 净利润 | $7.07B | $6.93B | $5.72B | $13.40B | $6.52B |
| 经营现金流 | $10.53B | $9.58B | $7.26B | $8.56B | $9.57B |
| 自由现金流 | $8.65B | $7.80B | $5.06B | $6.35B | $7.39B |
| 摊薄每股收益 | $3.94 | $3.91 | $3.26 | $7.64 | $3.72 |